Document is current

Any future updates will be listed below

Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer

Crossref DOI link: https://doi.org/10.1177/1933719118768684

Published Online: 2019-12-31

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark